Psychotic Disorders - Haiti | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$3.26m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.84%, resulting in a market volume of US$3.40m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$24.75 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Haiti is experiencing steady growth due to increasing customer preferences for effective treatment options and the presence of local special circumstances. Customer preferences in the Psychotic Disorders market in Haiti are shifting towards more advanced and innovative treatment options. Patients are seeking medications that not only alleviate symptoms but also provide long-term management of their condition. This has led to an increased demand for antipsychotic drugs that have a proven track record of efficacy and safety. Additionally, there is a growing interest in non-pharmacological interventions such as psychotherapy and social support programs, as patients and healthcare professionals recognize the importance of holistic approaches to treatment. The market is also being influenced by global trends in the Psychotic Disorders market. Worldwide, there is a growing awareness about mental health and a recognition of the need for improved access to care. This has led to increased investment in research and development of new treatments for psychotic disorders, which in turn has expanded the range of options available to patients in Haiti. Local special circumstances in Haiti are contributing to the development of the Psychotic Disorders market. The country has a high prevalence of mental health disorders, including psychotic disorders, which has created a significant demand for treatment options. However, there is a shortage of mental health professionals and limited access to healthcare facilities, particularly in rural areas. This has led to a reliance on primary care providers for the diagnosis and management of psychotic disorders, and an increased need for training and support for these healthcare professionals. Underlying macroeconomic factors are also driving the growth of the Psychotic Disorders market in Haiti. The country has experienced economic growth in recent years, which has resulted in an increase in healthcare spending. This has allowed for the expansion of mental health services, including the availability of medications and specialized treatment centers. Additionally, international organizations and non-governmental organizations have been working to improve access to mental healthcare in Haiti, further contributing to the development of the market. In conclusion, the Psychotic Disorders market in Haiti is growing due to changing customer preferences, global trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing demand for effective treatment options, the recognition of the importance of holistic approaches to care, and the expansion of mental health services are all driving the development of the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.